Evidence map›Paper›PMID 34200203›Full record

ArticleProteomes2021

Phosphorylation-Dependent Interactome of Ryanodine Receptor Type 2 in the Heart.

David Y Chiang, Satadru Lahiri, Guoliang Wang, Jason Karch, Meng C Wang, Sung Y Jung, Albert J R Heck, Arjen Scholten, Xander H T Wehrens

Open access · goldAbstract read
In one paragraph

Article in Proteomes, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 10 papers.

0numbers the graph read from it
0cells of the map it votes in
10citing papers in PubMed
0.9field-weighted citation impact, top 27% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

10 citing papers in PubMed, 14 citations in OpenAlex.

  1. Article
  2. Review
  3. Review
  4. Proteomics of the heart.Physiological reviews · 2024
    Review
  5. Article
  6. Cardiac function, structural, and electrical remodeling by microgravity exposure.American journal of physiology. Heart and circulatory physiology · 2023
    Review
  7. Role of CaArchives of toxicology · 2023
    Review
  8. Article
  9. Review
  10. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 4 institutions in 2 countries.

David Y ChiangCardiovascular Division, Department of Medicine, Harvard Medical School, Brigham and Women's Hospital, Boston, MA 02115, USA.ORCID 0000-0002-5883-6383
Satadru LahiriCardiovascular Research Institute, Department of Molecular Physiology & Biophysics, Baylor College of Medicine, Houston, TX 77030, USA.ORCID 0000-0001-9502-1530
Guoliang WangCardiovascular Research Institute, Department of Molecular Physiology & Biophysics, Baylor College of Medicine, Houston, TX 77030, USA.
Jason KarchCardiovascular Research Institute, Department of Molecular Physiology & Biophysics, Baylor College of Medicine, Houston, TX 77030, USA.
Meng C WangHuffington Center on Aging, Department of Molecular and Human Genetics, Baylor College of Medicine, Houston, TX 77030, USA.
Sung Y JungDepartment of Biochemistry, Baylor College of Medicine, Houston, TX 77030, USA.ORCID 0000-0003-1521-7977
Albert J R HeckBiomolecular Mass Spectrometry and Proteomics, Bijvoet Center for Biomolecular Research and Utrecht Institute for Pharmaceutical Sciences, Utrecht University, 3584 Utrecht, The Netherlands.
Arjen ScholtenBiomolecular Mass Spectrometry and Proteomics, Bijvoet Center for Biomolecular Research and Utrecht Institute for Pharmaceutical Sciences, Utrecht University, 3584 Utrecht, The Netherlands.
Xander H T WehrensCardiovascular Research Institute, Department of Molecular Physiology & Biophysics, Baylor College of Medicine, Houston, TX 77030, USA.ORCID 0000-0001-5044-672X
Baylor College of Medicine · USUtrecht University · NLBrigham and Women's Hospital · USHoward Hughes Medical Institute · US

Funding

Ryanodine receptor regulation in post-operative atrial fibrillationR01HL089598 · NHLBI · BAYLOR COLLEGE OF MEDICINE · PI WEHRENS, XANDER H.T. · 2007 to 2022
$6.5M
Partners Healthcare Training Program in Precision and Genomic MedicineT32HG010464 · NHGRI · MASSACHUSETTS GENERAL HOSPITAL · PI HEIDI L REHM, JORDAN W SMOLLER · 2019 to 2026
$3.1M
American Heart Association 18POST34080154Horizon 2020 Framework Programme 823839NHLBI NIH HHS R01HL089598NHLBI NIH HHS R01HL147188NHLBI NIH HHS R01HL153358NIH HHS T32HG010464
6 · The paper itself

Abstract

Hyperphosphorylation of the calcium release channel/ryanodine receptor type 2 (RyR2) at serine 2814 (S2814) is associated with multiple cardiac diseases including atrial fibrillation and heart failure. Despite recent advances, the molecular mechanisms driving pathological changes associated with RyR2 S2814 phosphorylation are still not well understood.

Indexed as

affinity-purification mass spectrometryatrial fibrillationheart failureinteractomephosphorylationRyR2

Identifiers

PMID34200203
PMCPMC8293434
OpenAlexW3167262572

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.